Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 17 | 2024 | 50 | 5.950 |
Why?
|
| Cochlear Implants | 12 | 2024 | 52 | 4.050 |
Why?
|
| Neuroma, Acoustic | 9 | 2024 | 28 | 2.820 |
Why?
|
| Hearing Loss, Sensorineural | 8 | 2025 | 144 | 2.500 |
Why?
|
| Cholesteatoma, Middle Ear | 5 | 2024 | 12 | 2.480 |
Why?
|
| Temporal Bone | 8 | 2021 | 36 | 2.000 |
Why?
|
| Otologic Surgical Procedures | 7 | 2023 | 23 | 1.940 |
Why?
|
| Hearing Loss | 5 | 2024 | 136 | 1.510 |
Why?
|
| Mastoid | 5 | 2024 | 24 | 1.440 |
Why?
|
| Tympanic Membrane | 2 | 2021 | 19 | 1.240 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 2021 | 5 | 1.220 |
Why?
|
| Encephalocele | 4 | 2020 | 50 | 1.210 |
Why?
|
| Fistula | 3 | 2021 | 48 | 1.180 |
Why?
|
| Mastoidectomy | 2 | 2024 | 6 | 1.110 |
Why?
|
| Speech Perception | 4 | 2024 | 49 | 1.050 |
Why?
|
| Granuloma | 2 | 2016 | 68 | 0.970 |
Why?
|
| Cerebellopontine Angle | 1 | 2025 | 6 | 0.950 |
Why?
|
| Ear Canal | 2 | 2023 | 9 | 0.940 |
Why?
|
| Lipoma | 1 | 2025 | 25 | 0.930 |
Why?
|
| Cholesterol | 3 | 2016 | 540 | 0.920 |
Why?
|
| Skull Base | 3 | 2021 | 53 | 0.880 |
Why?
|
| Cholesteatoma | 1 | 2023 | 6 | 0.820 |
Why?
|
| Neonatal Screening | 1 | 2024 | 187 | 0.810 |
Why?
|
| Cranial Sinuses | 2 | 2022 | 12 | 0.810 |
Why?
|
| Retrospective Studies | 31 | 2025 | 16334 | 0.800 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 223 | 0.790 |
Why?
|
| Ear, Middle | 4 | 2020 | 25 | 0.780 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 3597 | 0.770 |
Why?
|
| Tympanoplasty | 2 | 2024 | 9 | 0.750 |
Why?
|
| Ear Neoplasms | 3 | 2018 | 13 | 0.740 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2093 | 0.730 |
Why?
|
| Hemangioma, Capillary | 1 | 2021 | 17 | 0.730 |
Why?
|
| Adult | 39 | 2023 | 29452 | 0.720 |
Why?
|
| Craniotomy | 3 | 2017 | 105 | 0.710 |
Why?
|
| Ear, Inner | 1 | 2021 | 49 | 0.710 |
Why?
|
| Cerebellar Neoplasms | 1 | 2025 | 443 | 0.690 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2020 | 17 | 0.680 |
Why?
|
| Skull Neoplasms | 2 | 2017 | 14 | 0.670 |
Why?
|
| Quality of Life | 3 | 2024 | 1907 | 0.660 |
Why?
|
| Deafness | 1 | 2020 | 82 | 0.640 |
Why?
|
| Petrous Bone | 2 | 2015 | 5 | 0.630 |
Why?
|
| Humans | 71 | 2025 | 125025 | 0.630 |
Why?
|
| Middle Aged | 32 | 2021 | 26670 | 0.620 |
Why?
|
| Female | 47 | 2025 | 66669 | 0.620 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 2 | 2015 | 10 | 0.620 |
Why?
|
| Labyrinth Diseases | 1 | 2018 | 6 | 0.610 |
Why?
|
| Semicircular Canals | 1 | 2018 | 20 | 0.600 |
Why?
|
| Male | 45 | 2025 | 61429 | 0.600 |
Why?
|
| Electrodes, Implanted | 2 | 2016 | 168 | 0.590 |
Why?
|
| Neurotology | 1 | 2018 | 2 | 0.580 |
Why?
|
| Aged | 26 | 2020 | 19653 | 0.550 |
Why?
|
| Plasmacytoma | 1 | 2017 | 7 | 0.550 |
Why?
|
| Postoperative Complications | 7 | 2023 | 3044 | 0.550 |
Why?
|
| Facial Nerve | 4 | 2023 | 25 | 0.530 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 129 | 0.530 |
Why?
|
| Child | 19 | 2025 | 24609 | 0.530 |
Why?
|
| Tinnitus | 3 | 2022 | 19 | 0.520 |
Why?
|
| Marital Status | 1 | 2016 | 31 | 0.520 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 276 | 0.510 |
Why?
|
| Scala Tympani | 1 | 2016 | 3 | 0.510 |
Why?
|
| Cranial Fossa, Middle | 1 | 2015 | 1 | 0.500 |
Why?
|
| Vestibule, Labyrinth | 3 | 2023 | 43 | 0.490 |
Why?
|
| Glomus Tympanicum Tumor | 1 | 2015 | 1 | 0.480 |
Why?
|
| Surgical Mesh | 1 | 2015 | 61 | 0.470 |
Why?
|
| Treatment Outcome | 16 | 2024 | 12269 | 0.470 |
Why?
|
| Prednisone | 1 | 2015 | 278 | 0.460 |
Why?
|
| Temporal Lobe | 1 | 2015 | 113 | 0.460 |
Why?
|
| Fascia | 1 | 2014 | 14 | 0.460 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 88 | 0.450 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 690 | 0.420 |
Why?
|
| Adolescent | 15 | 2025 | 19412 | 0.420 |
Why?
|
| Perioperative Care | 1 | 2015 | 195 | 0.410 |
Why?
|
| Suture Techniques | 1 | 2014 | 193 | 0.410 |
Why?
|
| Facial Paralysis | 2 | 2023 | 34 | 0.400 |
Why?
|
| Glucocorticoids | 1 | 2015 | 383 | 0.400 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2015 | 206 | 0.400 |
Why?
|
| Hearing | 4 | 2023 | 53 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 729 | 0.370 |
Why?
|
| Pancreatectomy | 2 | 2010 | 137 | 0.370 |
Why?
|
| Young Adult | 12 | 2021 | 9054 | 0.370 |
Why?
|
| Glomus Jugulare Tumor | 3 | 2016 | 5 | 0.360 |
Why?
|
| Vestibular Diseases | 2 | 2023 | 67 | 0.360 |
Why?
|
| Stapes Surgery | 2 | 2021 | 4 | 0.360 |
Why?
|
| Otolaryngologists | 2 | 2020 | 9 | 0.350 |
Why?
|
| Headache | 2 | 2025 | 106 | 0.340 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 24 | 0.340 |
Why?
|
| Seizures | 1 | 2015 | 869 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2010 | 240 | 0.330 |
Why?
|
| Child, Preschool | 10 | 2025 | 14150 | 0.320 |
Why?
|
| Otolaryngology | 2 | 2020 | 106 | 0.300 |
Why?
|
| Radiosurgery | 4 | 2018 | 111 | 0.300 |
Why?
|
| Burnout, Professional | 2 | 2020 | 118 | 0.300 |
Why?
|
| Reoperation | 3 | 2024 | 828 | 0.300 |
Why?
|
| Kidney Neoplasms | 2 | 2010 | 439 | 0.290 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 6535 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 503 | 0.260 |
Why?
|
| Auditory Threshold | 2 | 2016 | 17 | 0.250 |
Why?
|
| Paraganglioma | 2 | 2014 | 20 | 0.230 |
Why?
|
| Operative Time | 2 | 2016 | 164 | 0.230 |
Why?
|
| Vestibular Function Tests | 2 | 2023 | 34 | 0.230 |
Why?
|
| Multilingualism | 1 | 2024 | 43 | 0.220 |
Why?
|
| Mass Screening | 2 | 2021 | 783 | 0.210 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2023 | 11 | 0.210 |
Why?
|
| Cautery | 1 | 2023 | 6 | 0.210 |
Why?
|
| Endoscopy | 3 | 2016 | 281 | 0.210 |
Why?
|
| Electrocoagulation | 1 | 2023 | 34 | 0.200 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Bell Palsy | 1 | 2021 | 5 | 0.190 |
Why?
|
| Earache | 1 | 2021 | 3 | 0.190 |
Why?
|
| Stapedius | 1 | 2021 | 1 | 0.190 |
Why?
|
| United States | 4 | 2024 | 10884 | 0.180 |
Why?
|
| Hearing Loss, Conductive | 1 | 2021 | 13 | 0.180 |
Why?
|
| Tendons | 1 | 2021 | 40 | 0.180 |
Why?
|
| Otosclerosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Audiometry | 2 | 2018 | 21 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 2516 | 0.180 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 3674 | 0.180 |
Why?
|
| Differential Threshold | 1 | 2020 | 11 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2023 | 4819 | 0.170 |
Why?
|
| Labyrinthitis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Meningioma | 1 | 2022 | 118 | 0.170 |
Why?
|
| Hydrocephalus | 1 | 2023 | 244 | 0.170 |
Why?
|
| Facial Nerve Diseases | 2 | 2021 | 6 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 29 | 0.170 |
Why?
|
| Physical Examination | 1 | 2021 | 158 | 0.170 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 192 | 0.160 |
Why?
|
| Skull Base Neoplasms | 1 | 2019 | 36 | 0.160 |
Why?
|
| Brain Stem | 1 | 2020 | 116 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1893 | 0.150 |
Why?
|
| SEER Program | 2 | 2016 | 202 | 0.150 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2018 | 5 | 0.150 |
Why?
|
| Neurilemmoma | 1 | 2018 | 43 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 14 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 54 | 0.140 |
Why?
|
| Postoperative Period | 2 | 2016 | 333 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2015 | 17 | 0.140 |
Why?
|
| Otitis Media | 2 | 2014 | 85 | 0.140 |
Why?
|
| Adenoma | 1 | 2018 | 127 | 0.140 |
Why?
|
| Acoustic Impedance Tests | 1 | 2016 | 7 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 63 | 0.130 |
Why?
|
| Audiology | 1 | 2016 | 5 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3402 | 0.130 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2015 | 10 | 0.130 |
Why?
|
| Ticlopidine | 1 | 2015 | 28 | 0.130 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2015 | 15 | 0.120 |
Why?
|
| Eustachian Tube | 1 | 2015 | 5 | 0.120 |
Why?
|
| Neurosurgical Procedures | 2 | 2018 | 300 | 0.120 |
Why?
|
| Dizziness | 1 | 2015 | 27 | 0.120 |
Why?
|
| Bone Plates | 1 | 2015 | 24 | 0.120 |
Why?
|
| Papilloma, Inverted | 1 | 2015 | 2 | 0.120 |
Why?
|
| Meningocele | 1 | 2015 | 19 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 305 | 0.120 |
Why?
|
| Age Distribution | 1 | 2016 | 418 | 0.120 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 20 | 0.120 |
Why?
|
| Glomus Tympanicum | 1 | 2014 | 2 | 0.120 |
Why?
|
| Meningitis | 1 | 2015 | 98 | 0.120 |
Why?
|
| Glomus Jugulare | 1 | 2014 | 1 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 18 | 0.120 |
Why?
|
| Cranial Nerve Diseases | 1 | 2015 | 26 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2015 | 43 | 0.120 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2014 | 7 | 0.120 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2014 | 41 | 0.110 |
Why?
|
| Warfarin | 1 | 2015 | 118 | 0.110 |
Why?
|
| Age of Onset | 1 | 2016 | 600 | 0.110 |
Why?
|
| Autografts | 1 | 2014 | 23 | 0.110 |
Why?
|
| Polyps | 1 | 2015 | 44 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 71 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 1023 | 0.110 |
Why?
|
| Aspirin | 1 | 2015 | 222 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 4683 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 265 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 1155 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 469 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2016 | 1252 | 0.100 |
Why?
|
| Pneumococcal Vaccines | 1 | 2014 | 169 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2015 | 203 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2054 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1316 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 469 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2016 | 3422 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8272 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2015 | 1016 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5167 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 693 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 2876 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 528 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2015 | 576 | 0.090 |
Why?
|
| Psychological Tests | 2 | 2020 | 90 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2014 | 1496 | 0.080 |
Why?
|
| Infant | 4 | 2024 | 12610 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 85 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 1653 | 0.080 |
Why?
|
| Keratotomy, Radial | 1 | 2009 | 33 | 0.080 |
Why?
|
| Mitomycin | 1 | 2009 | 49 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 961 | 0.080 |
Why?
|
| Photorefractive Keratectomy | 1 | 2009 | 80 | 0.080 |
Why?
|
| Incidence | 1 | 2016 | 3130 | 0.080 |
Why?
|
| Hyperopia | 1 | 2009 | 83 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3310 | 0.070 |
Why?
|
| Cochlea | 2 | 2020 | 87 | 0.070 |
Why?
|
| Self Report | 2 | 2020 | 508 | 0.070 |
Why?
|
| Myopia | 1 | 2009 | 192 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2009 | 818 | 0.060 |
Why?
|
| Child Language | 1 | 2024 | 31 | 0.060 |
Why?
|
| Phonetics | 1 | 2024 | 41 | 0.060 |
Why?
|
| Speech | 1 | 2024 | 62 | 0.060 |
Why?
|
| Prevalence | 2 | 2020 | 2458 | 0.050 |
Why?
|
| Caloric Tests | 1 | 2023 | 7 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2024 | 58 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2024 | 156 | 0.050 |
Why?
|
| Vertigo | 1 | 2023 | 35 | 0.050 |
Why?
|
| Ecosystem | 1 | 2024 | 77 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 1630 | 0.050 |
Why?
|
| Language | 1 | 2024 | 195 | 0.050 |
Why?
|
| Head | 1 | 2023 | 104 | 0.050 |
Why?
|
| Arachnoid | 1 | 2022 | 8 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 51 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1275 | 0.050 |
Why?
|
| Face | 1 | 2023 | 179 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 625 | 0.050 |
Why?
|
| Decision Trees | 1 | 2022 | 50 | 0.050 |
Why?
|
| Chorda Tympani Nerve | 1 | 2021 | 2 | 0.050 |
Why?
|
| Round Window, Ear | 1 | 2021 | 2 | 0.050 |
Why?
|
| Ligaments | 1 | 2021 | 19 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 236 | 0.050 |
Why?
|
| Bone Conduction | 1 | 2021 | 4 | 0.050 |
Why?
|
| Prolapse | 1 | 2021 | 11 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2021 | 73 | 0.050 |
Why?
|
| Vital Signs | 1 | 2021 | 21 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 291 | 0.040 |
Why?
|
| Internship and Residency | 2 | 2020 | 1178 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 566 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2019 | 53 | 0.040 |
Why?
|
| Caregivers | 1 | 2024 | 540 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 228 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 250 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 858 | 0.040 |
Why?
|
| Vestibulocochlear Nerve Injuries | 1 | 2018 | 1 | 0.040 |
Why?
|
| Facial Nerve Injuries | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 121 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gadolinium | 1 | 2018 | 109 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 439 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 43 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 780 | 0.030 |
Why?
|
| Sutures | 1 | 2017 | 64 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 835 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 130 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2015 | 13 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 68 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2181 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2015 | 69 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2015 | 185 | 0.030 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2014 | 25 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 71 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 152 | 0.030 |
Why?
|
| Microsurgery | 1 | 2015 | 69 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2014 | 102 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 78 | 0.030 |
Why?
|
| Ethmoid Sinus | 1 | 2014 | 9 | 0.030 |
Why?
|
| Nose Neoplasms | 1 | 2014 | 32 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 802 | 0.030 |
Why?
|
| Orbit | 1 | 2014 | 102 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 190 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 308 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 880 | 0.020 |
Why?
|
| Hypertension | 1 | 2021 | 1286 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2083 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2024 | 4595 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1095 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1187 | 0.020 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2010 | 55 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 1172 | 0.020 |
Why?
|
| Robotics | 1 | 2010 | 106 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2244 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2010 | 151 | 0.020 |
Why?
|
| Corneal Topography | 1 | 2009 | 198 | 0.020 |
Why?
|
| Refraction, Ocular | 1 | 2009 | 303 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1237 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 6296 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10278 | 0.010 |
Why?
|